Genexine, Inc. (KOSDAQ:095700)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Biotechnology	4.43B	16.14B	36.83B	18.54B	11.30B
Biotechnology Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%
Total	4.43B	16.14B	36.83B	18.54B	11.30B
Total Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
South Korea	1.72B	1.70B	2.90B	9.87B	11.30B
South Korea Growth	1.43%	-41.34%	-70.65%	-12.64%	101.16%
Asia	25.01M	9.95B	29.92B	689.79M	-
Asia Growth	-99.75%	-66.73%	4237.17%	-	-
Americas	2.68B	4.49B	4.01B	7.98B	-
Americas Growth	-40.31%	11.77%	-49.70%	-	-
Total	4.43B	16.14B	36.83B	18.54B	11.30B
Total Growth	-72.57%	-56.18%	98.61%	64.06%	80.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error